Bone Biologics - Warrants (13/10/2026) Current Cash

As of the most recent data (September 2026), BBLGW shows a current cash of $6.1M. That compares with $6M in the prior-year period — up 0.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BBLGW's current cash is now $6.1M (was $6M) — a 0.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Bone Biologics - Warrants (13/10/2026) is outperforming or lagging.

Tracking BBLGW's current cash over time shows whether Bone Biologics - Warrants (13/10/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $6.1M That compares with $6M in the prior-year period — up 0.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Bone Biologics - Warrants (13/10/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $6.1M) with ownership activity and broader fundamentals.